首页> 外文期刊>Clinical nuclear medicine >Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
【24h】

Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.

机译:F-18 FDOPA,F-18 FDG和F-18 FLT-PET / CT对低级神经胶质瘤代谢成像的比较评估。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

INTRODUCTION: We undertook this prospective study to compare amino acid metabolism, glucose metabolism, and proliferation in primary and recurrent low grade gliomas using positron emission tomography (PET)/computed tomography with F-18 FDOPA, F-18 FDG, and F-18 FLT. METHODS: Fifteen patients with newly diagnosed or previously treated low grade gliomas (WHO grade I or II) were subjected to F-18-FDOPA, F-18 FDG, and F-18 FLT PET/computed tomography studies on consecutive days. This included 2 patients in remission as control subjects. Uptake of all the 3 tracers were analyzed visually and quantified using standardized uptake values and tumor to normal (T/N) ratios. The accuracy of all the 3 PET tracers in the detection of newly diagnosed and recurrent low grade gliomas was compared. RESULTS: F-18 FDOPA was positive in all cases of primary and recurrent low grade gliomas and negative in the patients in remission. Tumor was visualized on F-18 FDG in 7 of 13 cases, F-18-FLT was positive in 4 of 13 cases. Average tumor standardized uptake values max for F-18 FDOPA (5.75 +/- 4.9) and F-18 FLT (1.8 +/- 0.91) was lower than that of F-18 FDG (8.5 +/- 4.4). T/N ratios for F-18-FDOPA (2.3 +/- 0.51) and F-18 FLT (1.8 +/- 0.91) were higher than F-18 FDG (1.03 +/- 0.64) providing good image contrast for tumor detection in positive cases. CONCLUSION: F-18 FDOPA scan is superior to both F-18 FLT and F-18 FDG for visualization of primary and recurrent low grade gliomas. F-18-FLT should not be considered for evaluation of recurrent low grade gliomas.
机译:简介:我们进行了这项前瞻性研究,以比较使用F-18 FDOPA,F-18 FDG和F-18的正电子发射断层扫描(PET)/计算机断层扫描来比较原发性和复发性低度胶质瘤的氨基酸代谢,葡萄糖代谢和增殖FLT。方法:对15例新诊断或先前治疗过的低级神经胶质瘤(WHO I级或II级)患者,连续进行F-18-FDOPA,F-18 FDG和F-18 FLT PET /计算机断层扫描研究。这包括2例缓解的患者作为对照对象。视觉分析所有3种示踪剂的摄取,并使用标准化摄取值和肿瘤与正常(T / N)之比进行定量。比较了所有3种PET示踪剂在检测新诊断和复发的低度神经胶质瘤中的准确性。结果:F-18 FDOPA在所有原发性和复发性低度神经胶质瘤病例中均为阳性,而在缓解期患者中均为阴性。 13例中有7例在F-18 FDG上可见肿瘤,13例中有4例F-18-FLT阳性。 F-18 FDOPA(5.75 +/- 4.9)和F-18 FLT(1.8 +/- 0.91)的平均肿瘤标准化最大摄取值低于F-18 FDG(8.5 +/- 4.4)。 F-18-FDOPA(2.3 +/- 0.51)和F-18 FLT(1.8 +/- 0.91)的T / N比高于F-18 FDG(1.03 +/- 0.64),为肿瘤检测提供了良好的图像对比度在积极的情况下。结论:对于原发性和复发性低度胶质瘤,F-18 FDOPA扫描优于F-18 FLT和F-18 FDG。 F-18-FLT不应用于评估复发性低度神经胶质瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号